Administrative and claims databases are attractive for safety studies of anticoagulant and antithrombotic drugs. However, the validity of such data is often uncertain. It was our aim to assess the usefulness of the Swedish administrative health databases for detection of major bleeding events. All individuals with atrial fibrillation in Stockholm County from 2006 to 2013 (n=78,022) were identified from the Swedish Patient register. A search for bleeding diagnoses was done in the Patient register and in the Cause of Death register. The medical records of a random sample of 761 patients were studied and classified in a blinded and pre-specified way. The highest sensitivity (99.5 %) and specificity (94.0 %) were obtained by counting fatal bleeding events with the bleeding diagnosis recorded as first or second cause of death, and all hospitalisations without regard to the position of the diagnosis. Codes for transfusions were unreliable and did not increase accuracy. The registries identified 99.4 % of intracranial bleeding events and 82.6 % of gastrointestinal bleeding events correctly. All patients classified as "no bleedings" were indeed without bleeding. Overall the sensitivity was 85.5 % and the specificity 95.9 % for major bleeding events. In conclusion, Swedish nationwide health registries are well suited for conducting outcome studies involving identification of bleeding events. The use of a diagnostic code for bleeding, irrespective of its position as primary or secondary diagnosis, provided the best sensitivity and specificity for detection of bleeding events, as long as it was limited to contacts resulting in hospital admission.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1160/TH16-05-0400 | DOI Listing |
Curr Cardiol Rep
January 2025
Division of Cardiology, NYU Grossman School of Medicine, New York, NY, USA.
Purpose Of Review: This review assesses the outcomes of coronary interventions in patients with liver cirrhosis and coronary artery disease (CAD), focusing on the clinical challenges posed by cirrhosis-related hemodynamic and coagulopathic changes. It highlights essential considerations for managing these patients, who have an increased risk of adverse events during coronary procedures.
Recent Findings: Recent studies have shown that patients with liver cirrhosis undergoing PCI experience significantly higher mortality rates compared to non-cirrhotic patients, particularly in the context of STEMI and NSTEMI.
Int J Stroke
January 2025
Department of Neurosurgery and Interventional Neuroradiology, Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological Disorders, 45 Changchun St, Beijing 100053, China.
Rationale: The Chemical Optimization of Cerebral Embolectomy (CHOICE) trial suggested that the administration of intra-arterial alteplase after successful endovascular thrombectomy (EVT) may improve neurological outcomes in patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO) in the anterior circulation. However, the use of adjunctive intra-arterial alteplase following successful EVT in acute posterior circulation stroke remains unexplored.
Aims: This study aims to investigate the efficacy and safety of intra-arterial alteplase after successful EVT for AIS-LVO in the posterior circulation.
Singapore Med J
January 2025
Department of Radiology, Armed Forces Institute of Radiology, Pakistan.
Introduction: We explored the efficacy and safety of dual antiplatelet therapy (DAPT) for individuals diagnosed with stroke or transient ischaemic attack (TIA), incorporating the latest insights from randomised controlled trials (RCTs). The emerging evidence surrounding DAPT in stroke and TIA plays a pivotal role in guiding clinical decisions.
Methods: Our study included five RCTs (INSPIRES, THALES, POINT, CHANCE, FASTER) on DAPT (aspirin + P2Y12 inhibitor) initiated within 72 hours of acute stroke or TIA, which evaluated DAPT efficacy and safety over 21-90 days, focusing on new strokes and major bleeding.
J Stroke Cerebrovasc Dis
January 2025
Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY, USA. Electronic address:
Background: The efficacy and safety of P2Y12 inhibitors (P2Y12i) with aspirin in patients with non-cardioembolic ischemic cerebrovascular events remains a topic of ongoing debate. Therefore, we conducted an updated meta-analysis to compare these drugs with aspirin alone.
Methods: We systematically searched PubMed, Embase, and Cochrane Central for randomized controlled trials (RCTs) comparing the two treatment regimens in patients with ischemic cerebrovascular events.
World J Urol
January 2025
Department of Urology, Charité - Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Purpose: The objective of this study was to evaluate the perioperative outcomes and complications associated with the use of acetylsalicylic acid (ASA) in deceased donor kidney transplantation (KTX), with a particular focus on bleeding events.
Methods: We retrospectively analyzed 157 kidney transplant recipients (KTRs) who underwent KTX at Charité Berlin, Department for Urology, between February 2014 and December 2017. Patients were divided into two groups: patients with ASA in their preoperative medication (Group A, n = 59) and patients without ASA use (Group B, n = 98).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!